Related Experiment Video

Updated: May 28, 2026

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
11:44

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice

Published on: March 24, 2015

Clinical implications of chemokines in acute and chronic hepatitis C virus infection

Wonseok Kang1, Eui-Cheol Shin

  • 1Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea.

Yonsei Medical Journal
|October 27, 2011
PubMed

Insights

Chemokines are crucial in Hepatitis C virus (HCV) infection. Their role shifts from clearing the virus in acute stages to promoting chronic liver inflammation and injury in persistent infections.

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Background:

  • Hepatitis C virus (HCV) is a major cause of chronic liver disease, including cirrhosis and liver cancer.
  • Most individuals infected with HCV fail to clear the virus, leading to chronic hepatitis C.
  • Chemokines are key regulators of immune cell trafficking and response during viral infections.

Purpose of the Study:

  • To review the dual role of chemokines in acute and chronic Hepatitis C virus (HCV) infection.
  • To explore the clinical significance of chemokines in managing HCV infection and treatment.

Main Methods:

  • Literature review of studies on chemokine function in HCV infection.
  • Analysis of chemokine roles in immune cell recruitment and liver injury.
  • Examination of clinical data relating chemokines to HCV treatment outcomes.

Main Results:

  • During acute HCV infection, chemokines facilitate immune cell recruitment for viral clearance.
  • In chronic HCV infection, sustained chemokine production drives persistent inflammation and liver damage.
  • Chemokine profiles correlate with disease progression and may inform therapeutic strategies.

Conclusions:

  • Chemokines play a critical, context-dependent role in the pathogenesis of Hepatitis C virus infection.
  • Understanding chemokine dynamics is essential for developing effective treatments for chronic hepatitis C.
  • Targeting chemokines may offer a novel therapeutic approach for HCV-related liver diseases.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...